NHS Framework Agreement for the supply of Ranibizumab for the NHS in England
NHS England · Closed
- Buyer
- NHS England
- Status
- Closed
- Country
- United Kingdom
- Region
- England
- Sector
- Manufacturing
- Reference
- FaT-ocds-h6vhtk-0395f7
- Published
- 2023-01-09
- Deadline
- 2023-02-10
Tender summary
The Procurement relates to the supply of ranibizumab an Anti Veg-F medicine used in medical retinal vascular services for the NHS in England. Anti Veg-F medicines are currently used in the treatment of: a. neovascular (wet) age-related macular degeneration (AMD); b. visual impairment due to diabetic macular oedema (DME/DMO); c. visual impairment due to myopic choroidal neovascularisation (myopic CNV); and d. visual impairment due to macular oedema secondary to retinal vein occlusion (branch RVO or central RVO).
This is a public summary of a procurement notice. Dates and status reflect the notice held by BidScout; check the full notice before bidding.
Full tender details have a three-minute guest preview for open opportunities. AI insights require registration.
Register for full access